Connected profiles1
Exact peptide identities attached to retained registry observations carrying this condition label.
Coverage-gated living condition brief
Osteoporosis, Postmenopausal peptide evidence brief
A cited Osteoporosis, Postmenopausal peptide evidence brief across 3 exact-label ClinicalTrials.gov records, 1 connected profile, and 3 registry-update years. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
Registry records
3 selected records.
Connected peptides
1 profiles.
Registry update years
2006–2026 in selected records.
Direct collection answer · published August 17, 2026
What peptide evidence does PeptideScanner carry for Osteoporosis, Postmenopausal?
PeptideScanner’s selected collection contains 3 retained ClinicalTrials.gov records carrying the exact condition label “Osteoporosis, Postmenopausal,” connected to 1 peptide profile across 3 registry-update years.
That answer describes this collection and the exact cited registry observations below. It is not a conclusion about whether any peptide treats Osteoporosis, Postmenopausal, and it is not a safety or efficacy assessment.
Indication intelligence
Selected evidence landscape
Trial phases2
Phase labels copied from the retained ClinicalTrials.gov versions.
Phase 4 (1)Phase 3 (1)
Registry statuses2
Overall statuses at each retained observation, not necessarily current today.
Completed (2)Recruiting (1)
Across the connected peptide profiles, PeptideScanner also carries 55 selected PubMed records and 6 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Osteoporosis, Postmenopausal unless their own cited source says so.
Related profile context
Literature connected through these peptide profiles
This is a bounded sample of up to six PubMed bibliography records connected through peptide profiles on this hub, not the total profile literature count above. They are not condition-matched records, and their presence does not establish that they concern Osteoporosis, Postmenopausal.
Teriparatide · source record 2026-08-13
Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
PubMed lists PMID 31408164 in The Journal of clinical endocrinology and metabolism as Comment, Letter, with publication-date metadata of 2019-12-01 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Teriparatide · source record 2026-08-13
Targeted drug repurposing in medication-related osteonecrosis of the jaw: a review of teriparatide and pentoxifylline/α-tocopherol protocols.
PubMed lists PMID 41852535 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2026-03-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Teriparatide · source record 2026-08-13
Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB.
PubMed lists PMID 41987916 in JIMD reports as Journal Article, with publication-date metadata of 2026-04-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Teriparatide · source record 2026-08-13
Comparing Teriparatide and Bisphosphonates for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of RCTs.
PubMed lists PMID 42022682 in Health science reports as Journal Article, Review, with publication-date metadata of 2026-03-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Teriparatide · source record 2026-08-13
Acute use of teriparatide and palopegteriparatide in the management of hungry bone syndrome following parathyroidectomy.
PubMed lists PMID 42058698 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2026-04-28 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Teriparatide · source record 2026-08-13
A Comparison Between Bisphosphonates and Teriparatide in the Treatment of Postmenopausal Osteoporosis: A Systematic Review.
PubMed lists PMID 42083710 in Cureus as Journal Article, Review, with publication-date metadata of 2026-04-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
Record added
ClinicalTrials.gov record NCT00035256
PeptideScanner retained ClinicalTrials.gov record NCT00035256 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-05-15, and PeptideScanner's reviewed identity mapping was teriparatide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- May 15, 2007
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT00046137
PeptideScanner retained ClinicalTrials.gov record NCT00046137 at 2026-07-30T22:49:18.183Z. Its registry update date was 2006-07-20, and PeptideScanner's reviewed identity mapping was teriparatide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- July 20, 2006
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT06164795
PeptideScanner retained ClinicalTrials.gov record NCT06164795 at 2026-08-10T18:10:03.919Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was teriparatide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- July 22, 2026
- Evidence lane
- Clinical trials
Exact-record source chronology
Osteoporosis, Postmenopausal registry timeline
Years come from the last-update date on each retained ClinicalTrials.gov observation. They show source chronology, not when PeptideScanner added the record and not a continuous monitoring guarantee.
2026
1 recordTeriparatide · 2026-07-22
ClinicalTrials.gov record NCT06164795
Recruiting at the retained observation.
Open cited registry record →2007
1 recordTeriparatide · 2007-05-15
ClinicalTrials.gov record NCT00035256
Completed at the retained observation.
Open cited registry record →2006
1 recordTeriparatide · 2006-07-20
ClinicalTrials.gov record NCT00046137
Completed at the retained observation.
Open cited registry record →- Condition matching is limited to exact labels on retained ClinicalTrials.gov v3 observations; PeptideScanner does not merge related diagnoses or synonyms.
- Coverage is selective and historical, not a complete or continuously current account of the registry or PubMed.
- The brief does not synthesize study outcomes, compare interventions, or make safety, efficacy, diagnosis, or treatment claims.